Infectious CNS Disease As a Differential Diagnosis in Systemic

Infectious CNS Disease As a Differential Diagnosis in Systemic

50 EXTENDED REPORT Ann Rheum Dis: first published as 10.1136/ard.62.1.50 on 1 January 2003. Downloaded from Infectious CNS disease as a differential diagnosis in systemic rheumatic diseases: three case reports and a review of the literature K Warnatz, H H Peter, M Schumacher, L Wiese, A Prasse, F Petschner, P Vaith, B Volk, S M Weiner ............................................................................................................................. Ann Rheum Dis 2003;62:50–57 Background: Immunosuppressive treatment of rheumatic diseases may be associated with several opportunistic infections of the brain. The differentiation between primary central nervous system (CNS) involvement and CNS infection may be difficult, leading to delayed diagnosis. See end of article for Objective: To differentiate between CNS involvement and CNS infection in systemic rheumatic authors’ affiliations diseases. ....................... Methods and results: Three patients with either longstanding or suspected systemic rheumatic Correspondence to: diseases (systemic lupus erythematodes, Wegener’s granulomatosis, and cerebral vasculitis) who pre- Dr S M Weiner, sented with various neuropsychiatric symptoms are described. All three patients were pretreated with Marienhospital, different immunosuppressive drugs (leflunomide, methotrexate, cyclophosphamide) in combination with Medizinische Klinik I, corticosteroids. Magnetic resonance imaging of the brain was suggestive of infectious disease, which Ruhr-Universität Bochum, Hölkeskampring 40, was confirmed by cerebrospinal fluid analysis or stereotactic brain biopsy (progressive multifocal leuco- 44625 Herne, Germany; encephalopathy (PML) in two and nocardiosis in one patient). stefan.weiner@ Discussion: More than 20 cases of PML or cerebral nocardiosis in patients receiving corticosteroids ruhr-uni-bochum.de and cytotoxic drugs for rheumatic disease have been reported. The clinical aspects of opportunistic Accepted 15 May 2002 CNS infections and the role of brain imaging, cerebrospinal fluid analysis and stereotactic brain ....................... biopsy in the differential diagnosis are reviewed. entral nervous system (CNS) involvement may become aneurysms, stenosis) and, if possible, stereotactic biopsy.17–19 a severe complication of several autoimmune disorders. MRI findings include infarction and white matter lesions, but In systemic lupus erythematosus (SLE) between 18 and both are non-specific.20 21 The diagnosis of this entity remains http://ard.bmj.com/ C 1–5 67% of patients have CNS involvement. Symptoms include problematic and requires the exclusion of more common psychosis, mood disorders, seizures, acute confusional states, conditions.22 stroke, migraine, chorea, aseptic meningitis, transverse Other autoimmune diseases with common CNS involve- myelopathy, as well as subtle cognitive impairment.6 There are ment include polyarteritis nodosa, antiphospholipid antibody no specific laboratory or magnetic resonance imaging (MRI) syndrome, and Behçet’s disease.23 24 findings, making a proper diagnosis often difficult. MRI may Chronic dysregulation of the immune system in conjunc- be negative despite overt neuropsychiatric symptoms.78 tion with immunosuppressive treatment predisposes patients Cerebrospinal fluid (CSF) analyses may show mild lym- with systemic autoimmune diseases to infections. Therefore on September 28, 2021 by guest. Protected copyright. phocytic pleocytosis, raised protein levels, and IgG indices as the new onset of CNS symptoms always leads to the suspicion well as oligoclonal bands in 25–50% of cases.910In up to 81% of underlying infections in the differential diagnosis of these of the cases CNS lupus may occur without systemic SLE patients. activity,4 often leading to a delayed diagnosis. Several viruses, bacteria, and fungi can imitate the clinical In Wegener’s granulomatosis (WG) cerebral involvement is and the radiological picture of CNS involvement of the rare (2–8%).11–13 Forty years ago a review by Drachman primary autoimmune diseases. Therefore careful evaluation of described three patterns of CNS involvement in WG14:(a) vas- the CNS manifestation is essential because the impact on the culitic changes; (b) meningeal involvement due to adjacent therapeutic decision is great. However, the diagnostic proce- granulomatous disease; and (c) isolated granulomatous dure is limited by time because in all patients with severe CNS meningocerebral lesions. In recent MRI studies Murphy et al involvement prompt treatment should be instituted in order to reported about 30% meningeal thickening and contrast preserve the maximum of cerebral function. In this paper we enhancement, 26% meningeal involvement by extracerebral report the cases of three patients with infectious CNS involve- granulomatous disease, 20% cerebral infarcts, and about 50% ment imitating autoimmune disorders. We also review the lit- non-specific white matter lesions.15 The main clinical manifes- erature and suggest a standard diagnostic procedure in tations are headache, seizure, or loss of function owing to focal lesion and stroke. Usually the diagnosis of WG is well ............................................................. established before CNS involvement occurs.16 There are no specific findings in WG suggesting CNS involvement. CSF Abbreviations: ANA, antinuclear antibodies; ANCA, antineutrophil analysis often shows only a slight rise in protein and a mild cytoplasmic antibodies; CMV, cytomegalovirus; CNS, central nervous lymphocytic pleocytosis. The diagnosis is made by clinical system; CRP, C reactive protein; CSF, cerebrospinal fluid; EBV, findings, MRI of the CNS, and histology. Epstein-Barr virus; HIV, human immunodeficiency virus; HSV, herpes 17 simplex virus; IV, intravenous; MRI, magnetic resonance imaging; PCR, Primary angiitis of the CNS is a very rare disorder. The polymerase chain reaction; PML, progressive multifocal diagnosis is based on the presence of neurological dysfunc- leucoencephalopathy; SLE, systemic lupus erythematosus; VZV, varicella tion, angiographic features of vasculitis (vessel irregularity, zoster virus; WG, Wegener’s granulomatosis www.annrheumdis.com Infectious CNS disease in systemic rheumatic diseases 51 intensity on T1 weighted imaging. CSF analysis showed a nor- Ann Rheum Dis: first published as 10.1136/ard.62.1.50 on 1 January 2003. Downloaded from mal cell count, an increased total protein content (652 mg/l), an IgG index of 0.5, and positive oligoclonal bands. A stereotactic brain biopsy was performed that showed abnor- mal oligodendroglial cells, demyelination, and swollen astro- cytes associated with inflammatory cell infiltrates, suggesting the diagnosis of progressive multifocal leucoencephalopathy (PML). The diagnosis was confirmed by electron microscopy (fig 1B) and the detection of JC virus DNA in the brain tissue (nested polymerase chain reaction (PCR)) and in CSF samples (quantitative PCR). Tests for human immunodeficiency virus (HIV), cytomegalovirus (CMV) antigen, CMV-RNA, and anti- toxoplasma IgM antibodies were negative. Leflunomide was stopped and the drug elimination was hastened by a two week treatment with cholestyramine. Within three weeks the neurological status worsened, lead- ing to a progressive motor weakness of the right side, a central paresis of the facial nerve, and a central impairment of blad- der function. An MRI follow up disclosed progressive brain lesions. Antiviral treatment was started with 5 mg/kg cidofo- vir every two weeks. The course of the disease was fluctuating with phases of progression followed by phases of clear improvement of the neurological deficits. Patient 2 Four years before admission a 52 year old white man had been diagnosed with WG. After a new onset of haemoptysis, proteinuria, scleritis, and arthralgias, diagnosis was histologi- cally proved by a necrotising, granulomatous vasculitis in a Figure 1 (A) Coronal MRI scan of the brain showing confluent foci bronchial biopsy specimen and by a positive cANCA (titre (arrows) of hyperintensity in the deep and subcortical white matter and subdural space on inversion recovery sequences (patient 1). (B) 1/100, anti-PR3 positive). With oral cyclophosphamide (2 Electron micrograph of a brain biopsy specimen (patient 1): Nucleus mg/kg body weight) the clinical course stabilised, except for a of a transformed oligodendrocyte with multiple electron dense residual proteinuria of 0.5 g/day. After 29 months of particles typical for polyoma viruses (arrow). Magnification cyclophosphamide treatment (total dose 95 g), treatment was ×66 300. changed to methotrexate. Two months before admission, a slight increase in arthralgias and fever had developed. Because patients with pre-existing autoimmune disease and new onset of suspected WG relapse the treating family doctor increased of CNS disease. the daily steroid dose to 50 mg prednisolone a day. The patient was then admitted to our hospital. Because physical examina- http://ard.bmj.com/ tion, a computed tomography scan of the lungs, and CASE REPORTS laboratory investigations showed no signs of WG activity or of Patient 1 infection, the patient was discharged and tapering of A 33 year old woman was admitted to our hospital with pro- prednisolone was recommended. gressive personality alterations, impairment of concentration Three weeks later he was readmitted because of cough, and memory, difficulties in word finding, headache, and dys- fever, night sweats, and weight loss of 8 kg. Now, the C reactive arthria. Eleven years ago SLE was diagnosed

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    8 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us